Home > EU agency says J&J Covid-19 vaccine's benefits outweigh the risks

News
EU agency says J&J Covid-19 vaccine's benefits outweigh the risks

Description

Europe's medicines regulator says that blood clots should be listed as a very rare side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweigh the risks. SOUNDBITE

Added on the 20/04/2021 17:58:56 - Copyright : AFPTV - First images

To customise your video :

More videos on the subject

EMA review finds AstraZeneca benefits still outweigh risks

The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Co…

23/04/2021 - AFPTV - First imag…
Anti-vaccine protesters march against Covid-19…

23/01/2022 - AFPTV…
Nurse arrested in Palermo, pretends to administer Covid-1…

17/01/2022 - AFPTV…
Demonstrators gather in Paris to protest Covid-19 vaccine pass

Hundreds of opponents of the Covid-19 vaccine pass gather near the Eiffel Tour in Paris to protest against the controver…

15/01/2022 - AFPTV - First imag…
Protests in Vienna against anti-Covid-19 measures

11/12/2021 - AFPTV…

News
EU agency says J&J Covid-19 vaccine's benefits outweigh the risks

More videos on the subject

EMA review finds AstraZeneca benefits still outweigh risks

Anti-vaccine protesters march against Covid-19…

Nurse arrested in Palermo, pretends to administer Covid-1…

Demonstrators gather in Paris to protest Covid-19 vaccine pass

Protests in Vienna against anti-Covid-19 measures

More videosNews

Ukraine: après la reprise de la ville, Zelensky...

DemainEntreprendre - épisode 12

Ouverture d'un nouveau secteur: combien de temps...

News EU agency says J&J Covid-19 vaccine's benefits outweigh the risks

More videos on the subject

More videosNews

News
EU agency says J&J Covid-19 vaccine's benefits outweigh the risks